
Pharmaceutical News
The multiple sclerosis treatment landscape has undergone dramatic changes over the past year. Biogen's Tecfidera has revolutionised multiple sclerosis treatment in the U.S.
Read moreDelveWin is an expert research firm in providing comprehensive knowledge-driven management solutions. DelveWin's solutions help the pharmaceutical and biotechnology industries to increase their marketing and brand effectiveness. Utilizing expert services and unique methodology, DelveWin's solutions integrate critical information communicating it to the right people, at the right time through a "Single Touch Point."
DelveWin has one of the industry’s most comprehensive approaches to data collection and evaluation, accounting for and weighing dozens of research streams.Delwin bring powerful benefits by identifying national, regional & local KOLs and their extent of influence facilitating continuous strategic use of the most influential KOLs throughout the organization.
Intellectual Property (IP) can mean the difference between success and failure in today’s competitive business world. The concepts of innovation, research & development, breakthrough, patent, copyright, trade secret and intellectual property are lifelines in the technology industries.
In an era of accelerating innovation and discovery, technology executives recognize that they must maximize the value of their portfolio of intellectual property. Intellectual Property has now become the most critical components of value creation for companies across the globe.
The multiple sclerosis treatment landscape has undergone dramatic changes over the past year. Biogen's Tecfidera has revolutionised multiple sclerosis treatment in the U.S.
Read moreThe Pharma Marketing News reprints and case studies relating to Key Opinion Leader Management and Medical Science Liaisons.KOL interested in categories for additional reprints relating to physician sales and marketing.
Read moreGSK announced via a carefully worded release that by 2016 it would no longer be directly funding speaking engagements or attendance at medical conferences for KOLs. KOL widely interpreted by media and commentators
Read more